Healthcare regulator says it will update recommendations ‘very soon’ in wake of row over jab’s effectiveness in older candidates
Germany could soon authorise the use of the AstraZeneca vaccine for seniors after the head of the country’s vaccination committee said his body’s advice to give the Oxford-developed vaccine only to those under 65 had “somehow gone wrong”.
Unlike the European Medicines Agency or Britain’s MHRA, Germany’s Standing Committee on Vaccination (Stiko) last month recommended against the use of the AstraZeneca vaccine on seniors, citing a lack of conclusive trial data to prove its efficacy in that age group.
We never criticised the vaccine, we just criticised the lack of data for the over-65 age group
